Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation

被引:0
|
作者
Chiara Maniaci
Scott J. Hughes
Andrea Testa
Wenzhang Chen
Douglas J. Lamont
Sonia Rocha
Dario R. Alessi
Roberto Romeo
Alessio Ciulli
机构
[1] University of Dundee,Division of Biological Chemistry and Drug Discovery, School of Life Sciences
[2] University of Dundee,Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences
[3] University of Dundee,Centre for Gene Regulation and Expression, School of Life Sciences
[4] University of Messina,Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali
[5] Polo Universitario Viale SS. Annunziata SNC,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
E3 ubiquitin ligases are key enzymes within the ubiquitin proteasome system which catalyze the ubiquitination of proteins, targeting them for proteasomal degradation. E3 ligases are gaining importance as targets to small molecules, both for direct inhibition and to be hijacked to induce the degradation of non-native neo-substrates using bivalent compounds known as PROTACs (for ‘proteolysis-targeting chimeras’). We describe Homo-PROTACs as an approach to dimerize an E3 ligase to trigger its suicide-type chemical knockdown inside cells. We provide proof-of-concept of Homo-PROTACs using diverse molecules composed of two instances of a ligand for the von Hippel-Lindau (VHL) E3 ligase. The most active compound, CM11, dimerizes VHL with high avidity in vitro and induces potent, rapid and proteasome-dependent self-degradation of VHL in different cell lines, in a highly isoform-selective fashion and without triggering a hypoxic response. This approach offers a novel chemical probe for selective VHL knockdown, and demonstrates the potential for a new modality of chemical intervention on E3 ligases.
引用
收藏
相关论文
共 46 条
  • [31] A patent review of von Hippel-Lindau (VHL)-recruiting chemical matter: E3 ligase ligands for PROTACs and targeted protein degradation (2019-present)
    Urbina, Aina
    Hallatt, Alex J.
    Robertson, Jack
    Ciulli, Alessio
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 35 (03) : 197 - 238
  • [32] Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation
    Bulatov, Emil
    Ciulli, Alessio
    BIOCHEMICAL JOURNAL, 2015, 467 : 365 - 386
  • [33] Mechanism-Based Small Molecule Cross-Linkers of HECT E3 Ubiquitin Ligase-Substrate Pairs
    Park, Sungjin
    Ntai, Ioanna
    Thomas, Paul
    Konishcheva, Evgeniia
    Kelleher, Neil L.
    Statsuk, Alexander V.
    BIOCHEMISTRY, 2012, 51 (42) : 8327 - 8329
  • [34] 3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein Degradation (vol 140, pg 9299, 2018)
    Testa, Andrea
    Lucas, Xavier
    Castro, Guilherme V.
    Chan, Kwok-Ho
    Wright, Jane E.
    Runcie, Andrew C.
    Gadd, Morgan S.
    Harrison, William T. A.
    Ko, Eun-Jung
    Fletcher, Daniel
    Ciulli, Alessio
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (18) : 7644 - 7644
  • [35] MALAT1 recruited the E3 ubiquitin ligase FBXW7 to induce CRY2 ubiquitin-mediated degradation and participated in trophoblast migration and invasion
    Wu, Lianzhi
    Liu, Qian
    Yin, Tailang
    Fan, Cuifang
    Yi, Xiaofang
    Cheng, Biheng
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (03) : 2169 - 2177
  • [36] Small-molecule inhibitors of SCF-Skp2-Cks1 ubiquitin E3 ligase stabilize nuclear p27kip1 as a novel therapeutic approach to endometrial cancer
    Egbuta, Chinaza
    Dubrulle, Julien
    Tellechea, Ana
    Manzanares, Miguel A.
    Li, Yunfeng
    Duan, Shanshan
    Dickson, John K.
    Meniconi, Mirco
    Huang, Kuo-sen
    Huang, Xinyan
    Shohdy, Nadim
    Pagano, Michelle
    Hao, Bing
    Mancini, Michael A.
    Gold, Leslie I.
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Discovery of Small-Molecule Inhibitors Targeting the E3 Ubiquitin Ligase Activity of the Herpes Simplex Virus 1 ICP0 Protein Using an In Vitro High-Throughput Screening Assay
    Deschamps, Thibaut
    Waisner, Hope
    Dogrammatzis, Christos
    Roy, Anuradha
    Chacko, Shibin
    Perera, Chamani
    Prisinzano, Thomas E.
    Kalamvoki, Maria
    JOURNAL OF VIROLOGY, 2019, 93 (13)
  • [38] Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants
    Offensperger, Fabian
    Mueller, Franziska
    Jansen, Jasmin
    Hammler, Daniel
    Goetz, Kathrin H.
    Marx, Andreas
    Sirois, Carissa L.
    Chamberlain, Stormy J.
    Stengel, Florian
    Scheffner, Martin
    CELL CHEMICAL BIOLOGY, 2020, 27 (12): : 1510 - +
  • [39] Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy
    Liu, Ting-Ting
    Yang, Heng
    Zhuo, Fang-Fang
    Yang, Zhuo
    Zhao, Mei-Mei
    Guo, Qiang
    Liu, Yang
    Liu, Dan
    Zeng, Ke-Wu
    Tu, Peng-Fei
    EBIOMEDICINE, 2022, 86
  • [40] The Ubiquitin E3 Ligase FBXO33 Suppresses Stem Cell-Like Properties and Metastasis in Non-Small-Cell Lung Cancer by Promoting Ubiquitination and Degradation of Myc
    Wei, Qiong
    Liu, Zichun
    Zhu, Jing
    Jiang, Wenyan
    Xie, Haiqin
    Feng, Ganzhu
    Wang, Keming
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (08):